Quick Take
Guardion Health Sciences (GHSI) intends to raise gross proceeds of $10 million from a U.S. IPO, according to an S-1 registration statement.
The firm provides condition-specific medical foods and vision testing solutions.
GHSI is seeking public capital at a difficult time in the IPO market, and the firm has relatively low sales to-date.
Company & Technology
San Diego, California-based GHSI was founded in 2009 to develop, formulate and distribute condition-specific medical foods.
Its first product is Lumega-Z that replenishes and restores the macular protective pigment, simultaneously delivering critical and essential